Sauer Paul 4
4 · Vaxcyte, Inc. · Filed May 25, 2022
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Sauer Paul
SVP Process Dev, Manufacturing
Transactions
- Sale
Common Stock
2022-05-23$26.22/sh−3,000$78,671→ 23,687 total
Footnotes (3)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $25.72 to $26.61. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes 1,562 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 17, 2022.